ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Sanofi

Sanofi (SNW)

96.47
1.07
( 1.12% )
Updated: 03:35:32
Realtime Data

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
96.47
Bid
96.23
Offer
96.37
Volume
3,248
94.90 Day's Range 96.63
0.00 52 Week Range 0.00
Market Cap
Previous Close
95.40
Open
95.48
Last Trade
170
@
96.47
Last Trade Time
03:26:45
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
1,252,640,466
Dividend Yield
3.90%
PE Ratio
22.34
Earnings Per Share (EPS)
4.31
Revenue
43.07B
Net Profit
5.4B

About Sanofi

Sector
Health & Allied Services,nec
Industry
Pharmaceutical Preparations
Website
Headquarters
Paris, Paris, Fra
Founded
1994
Sanofi is listed in the Health & Allied Services sector of the Tradegate (DE) with ticker SNW. The last closing price for Sanofi was 95.40 €. Over the last year, Sanofi shares have traded in a share price range of 0.00 € to 0.00 €.

Sanofi currently has 1,252,640,466 shares in issue. The market capitalisation of Sanofi is 119.50 € billion. Sanofi has a price to earnings ratio (PE ratio) of 22.34.

SNW Latest News

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma New Sarclisa subcutaneous formulation met co-primary endpoints in the...

Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III IRAKLIA dans le myélome multiple

Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III IRAKLIA dans le myélome multiple La nouvelle...

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins pneumococciques conjugués

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins...

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines Sanofi initiates phase 3 program for...

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Paris, le 19 décembre 2024. Le Conseil...

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors Jean-Paul Kress to join Sanofi's Board of Directors Paris, December 19, 2024. Sanofi's Board of Directors is pleased to...

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de...

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Duvakitug positive phase 2b results demonstrate best-in-class...

Press Release: Availability of the Q4 2024 Aide-mémoire

Press Release: Availability of the Q4 2024 Aide-mémoire Availability of the Q4 2024 Aide-mémoire Paris, France – December 17, 2024. Sanofi announced today that its Q4 2024 Aide-mémoire is...

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire »

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire » Mise en ligne du document « Q4 2024 Aide-mémoire » Paris, France, le 17 Décembre 2024. Sanofi annonce la mise en ligne...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

SNW - Frequently Asked Questions (FAQ)

What is the current Sanofi share price?
The current share price of Sanofi is 96.47 €
How many Sanofi shares are in issue?
Sanofi has 1,252,640,466 shares in issue
What is the market cap of Sanofi?
The market capitalisation of Sanofi is EUR 119.5B
What is the 1 year trading range for Sanofi share price?
Sanofi has traded in the range of 0.00 € to 0.00 € during the past year
What is the PE ratio of Sanofi?
The price to earnings ratio of Sanofi is 22.34
What is the cash to sales ratio of Sanofi?
The cash to sales ratio of Sanofi is 2.8
What is the reporting currency for Sanofi?
Sanofi reports financial results in EUR
What is the latest annual turnover for Sanofi?
The latest annual turnover of Sanofi is EUR 43.07B
What is the latest annual profit for Sanofi?
The latest annual profit of Sanofi is EUR 5.4B
What is the registered address of Sanofi?
The registered address for Sanofi is 46, AVENUE DE LA GRANDE ARMEE, PARIS, PARIS, 75017
What is the Sanofi website address?
The website address for Sanofi is www.sanofi.com
Which industry sector does Sanofi operate in?
Sanofi operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GTYGateway Real Estate AG
1.36 €
(178.69%)
861.74k
DBVDBV Technologies
1.28 €
(70.67%)
21.43k
K1SNKlondike Silver Corporation
0.0125 €
(47.06%)
158.5k
PBS0Precision Biosciences Inc
6.35 €
(44.32%)
4.46k
2OZAMicrovast Holdings Inc
2.459 €
(36.01%)
313.69k
QP9Atco Mining Inc
0.0032 €
(-73.33%)
30k
E3O1Nexoptic Technology Corp
0.0095 €
(-44.12%)
22.48k
CNWCodon AG
0.007 €
(-36.36%)
25
H5EHelma Eigenheimbau Ag
0.055 €
(-31.25%)
1.04k
L09Lithium Energi Exploration Inc
0.0155 €
(-31.11%)
47k
PF8European Lithium Limited
0.0328 €
(9.33%)
4.14M
D7GNel ASA
0.255 €
(2.53%)
2.57M
LHADeutsche Lufthansa AG
5.626 €
(-4.48%)
2.48M
QJ4Auric Minerals Corp
2.33 €
(-12.82%)
2.33M
G7PAEnergy Transition Minerals Ltd
0.0466 €
(-2.92%)
1.74M

Discussion

View Full Feed
Mojocash Mojocash 5 minutes ago
Many whacked libs blame Trump for the fires. So twisted.
shajandr shajandr 5 minutes ago
The core prollem is the failure to ban dancing in the Hollywood/SunsetBlvd music clubs during times when the Santa Ana winds are blowing Dixie, double-four time:

[yt]zcua9XzKVas[/yt]

https://secretlosangeles.com/best-clubs-los-angeles/
bar1080 bar1080 6 minutes ago
Great post. I've been told by one of my commercial landlords that installing sprinklers in his building would lower his fire insurance cost by 95%. But you have to have water for that to work. Also, sprinklers themselves can do a huge amount of damage, so alarms are required.

I worry
Mojocash Mojocash 6 minutes ago
Perhaps you should blame Jimmy Carter. Had he the courage to rescue the hostages from Iran, he would have served another term and there would not have been a Ronald Reagan in office. For Carter's domestic policy was top notch. Too bad he was a coward. Rest in Peace Jimmy Carter. Left Americans as ho
local 13 local 13 6 minutes ago
Michael Burry moment.. yes please 
FRZT
Jackxkr Jackxkr 7 minutes ago
In your ( right CO ?) mind everyone that is not happy with mgmt is a shorter , you are a bigger part of the problem than FUDsters as you like to call them. If you don't bring issues with mgmt to the forefront how do you solve them. Sticking your ( again) head up bas2020s butt and hiding is not the a
NWBO
Monksdream Monksdream 7 minutes ago
TRML under $20
https://investorshub.advfn.com/uimage/uploads/2025/1/9/fophhIMG_4525.gif
TRML
exwannabe exwannabe 7 minutes ago
Your post won’t age well, but you know that, and it’s why you did not bet on it, imo. I’ll take the approval bet against you specifically that I will not post if no approval by December 31, 2024, as long as you agree not to post if approval occurs before January 1, 2025.
A shame LC did not ac
NWBO
jazz_1 jazz_1 8 minutes ago
Really good WWE Raw debut on Netflix. Great match between CM Punk and Seth Rollins.
TKO
Iggy_Bot Iggy_Bot 8 minutes ago
The people are in shock and awe, wait till the anger kicks in
123tom 123tom 9 minutes ago
I'm interested in what you're saying. I agree the major price moves are institution driven.Do you have a sense of the timing and price targets .we're seeing the price gyrate 2 and 3 dollars up and down, , and the chart to my eyes, is looking like a support area around 10/10.50 to watch. I can't
AVXL
3331 3331 9 minutes ago
Of course it's a good sign - it shows that BIEL is always amongst the most watched stocks on IHUB (often with more reads than Tesla, NVIDIA, etc.), and many people are interested in investing.

Then, of course, there are those that were fired, or lost money in the past, that are here
BIEL
local 13 local 13 10 minutes ago
Baha mar in Nassau Bahamas? That is a Disney resorts style property (mini version only 1000 acres). Looks like Hyatt or Hilton is in there already, among others. Hong Kong owned per google search. What's the connection to frzt?
FRZT
tdbowieknife tdbowieknife 10 minutes ago
Yes, those winds could do ya in for sure... Check out your vents. Epically any eve and roof vents. Winds like that could also send something through a window and that would not be good. But ya still have a much better chance of coming back to something standing.



..
Monksdream Monksdream 10 minutes ago
ADMA under $19
https://investorshub.advfn.com/uimage/uploads/2025/1/9/slhdlIMG_4524.gif
ADMA
ronle ronle 11 minutes ago
F*U*
NXPL
Zorax Zorax 11 minutes ago
Orangedonshittypants probably will ask that MLK day be cancelled as well. It's on the 20th this year.
He's must be hating the hell out of that.
TMaga TMaga 12 minutes ago
Jimmie Carters' services saved the bad news till tomorrow. RIP Jimmie. We need a break from this corruption.
HCMC
TMaga TMaga 13 minutes ago
Jimmie Carters' services saved the bad news till tomorrow. RIP Jimmie. We need a break from this corruption.
HCWC
Mojocash Mojocash 13 minutes ago
Translation: I want to buy back in only cheaper.... lol
SANA
alertmeipp alertmeipp 14 minutes ago
I deliberately undervalued the royalty interest to emphasize how undervalued the stock currently is.

I agree on the timing of an RSV partnership, but it doesn’t matter much to me as long as it happens. The priority is getting the development costs covered, as you pointed out before.
ENTA PFE
PennyMillions852 PennyMillions852 14 minutes ago
LOL, love how you seem to have an answer for EVERYTHING.....you can put me back on ignore, you dont personally know those X posters after all just as I suspected.
IGPK
Monksdream Monksdream 15 minutes ago
MESO under $18
https://investorshub.advfn.com/uimage/uploads/2025/1/9/djdorIMG_4522.gif
MESO
Barron4664 Barron4664 16 minutes ago
Thanks Rick, read through the thread. Sounds great but all these experts including Ackman seem to not have read the Charter Act that says common shares can only be issued for appropriate capital. That means to anyone with common sense that Treasuries warrants are illegal. But I guess these experts d
FNMA

Your Recent History

Delayed Upgrade Clock